Is prostacyclin a physiologically important circulating anti-platelet agent?
- 1 January 1980
- journal article
- Published by Springer Nature in Nature
- Vol. 283 (5743), 194-195
- https://doi.org/10.1038/283194a0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The use of immobilized ligands and [125I] protein a for immunoassays of thromboxane B2, prostaglandin D2, 13,14-dihydro-prostaglandin E2, 5,6-dihydro-prostaglandin I2, 6-keto-prostaglandin F1α, 15-hydroxy-9α,11α(epoxymethano)prosta5, 13-dienoic acid and 15-hydroxy-11α,9α(epoxymethano)prosta-5,13-dienoic acidProstaglandins and Medicine, 1979
- Antibodies which antagonise the effects of prostacyclinNature, 1978
- Prostacyclin is a circulating hormoneNature, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSISBritish Medical Bulletin, 1978
- Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in plateletsNature, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- EFFECT OF VARIATION OF THE INTERVAL BETWEEN VENEPUNCTURE AND MEASUREMENT OF PLATELET ADHESIVENESS BY THE PAYLING WRIGHT METHODThe Lancet, 1967
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962